{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:54:34Z","timestamp":1788872074686,"version":"build-2803163510"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA025314"],"award-info":[{"award-number":["DA025314"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA01342"],"award-info":[{"award-number":["DA01342"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA032718"],"award-info":[{"award-number":["DA032718"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA033930"],"award-info":[{"award-number":["DA033930"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA037649"],"award-info":[{"award-number":["DA037649"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>\n                      Synthetic cathinones, commonly referred to as \u2018bath salts\u2019, are a group of amphetamine\u2010like drugs gaining popularity worldwide. 4\u2010\n                      <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>\n                      ethylmethcathinone (mephedrone,\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      ) is the most commonly abused synthetic cathinone in the\n                      <jats:styled-content style=\"fixed-case\">UK<\/jats:styled-content>\n                      , and exerts its effects by acting as a substrate\u2010type releaser at monoamine transporters. Similar to other cathinone\u2010related compounds,\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      has a chiral centre and exists stably as two enantiomers:\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010mephedrone (\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      ) and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010mephedrone (\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Approach<\/jats:title>\n                    <jats:p>\n                      Here, we provide the first investigation into the neurochemical and behavioural effects of\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010MEPH and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      . We analysed both enantiomers in rat brain synaptosome neurotransmitter release assays and also investigated their effects on locomotor activity (e.g. ambulatory activity and repetitive movements), behavioural sensitization and reward.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Both enantiomers displayed similar potency as substrates (i.e. releasers) at dopamine transporters, but\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      was much less potent than\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      <jats:italic>\u2010<\/jats:italic>\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      as a substrate at 5\u2010HT transporters. Locomotor activity was evaluated in acute and repeated administration paradigms, with\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      producing greater repetitive movements than\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      across multiple doses. After repeated drug exposure, only\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      produced sensitization of repetitive movements.\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      produced a conditioned place preference whereas\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      did not. Lastly,\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      produced biphasic profiles in an assay of intracranial self\u2010stimulation (\n                      <jats:styled-content style=\"fixed-case\">ICSS<\/jats:styled-content>\n                      ), but\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:styled-content>\n                      <jats:italic>\u2010<\/jats:italic>\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      produced greater\n                      <jats:styled-content style=\"fixed-case\">ICSS<\/jats:styled-content>\n                      facilitation than\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Implications<\/jats:title>\n                    <jats:p>\n                      Our data are the first to demonstrate stereospecific effects of\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      enantiomers and suggest that the predominant dopaminergic actions of\n                      <jats:italic>R\u2010<\/jats:italic>\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      (i.e. the lack of serotonergic actions) render this stereoisomer more stimulant\u2010like when compared with\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>S<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MEPH<\/jats:styled-content>\n                      . This hypothesis warrants further study.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bph.12951","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T01:07:56Z","timestamp":1411693676000},"page":"883-894","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Stereochemistry of mephedrone neuropharmacology: enantiomer\u2010specific behavioural and neurochemical effects in rats"],"prefix":"10.1111","volume":"172","author":[{"given":"Ryan A","family":"Gregg","sequence":"first","affiliation":[{"name":"Department of Pharmacology Temple University School of Medicine Philadelphia PA USA"},{"name":"Center for Substance Abuse Research Temple University School of Medicine Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Baumann","sequence":"additional","affiliation":[{"name":"Designer Drug Research Unit of the Intramural Research Program National Institute on Drug Abuse, National Institutes of Health Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Partilla","sequence":"additional","affiliation":[{"name":"Designer Drug Research Unit of the Intramural Research Program National Institute on Drug Abuse, National Institutes of Health Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie S","family":"Bonano","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology Virginia Commonwealth University Richmond VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vouga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Temple University School of Medicine Philadelphia PA USA"},{"name":"Center for Substance Abuse Research Temple University School of Medicine Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S","family":"Tallarida","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Temple University School of Medicine Philadelphia PA USA"},{"name":"Center for Substance Abuse Research Temple University School of Medicine Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Velvadapu","sequence":"additional","affiliation":[{"name":"Fox Chase Chemical Diversity Center Inc. Doylestown PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry R","family":"Smith","sequence":"additional","affiliation":[{"name":"Fox Chase Chemical Diversity Center Inc. Doylestown PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Melissa","family":"Peet","sequence":"additional","affiliation":[{"name":"Department of Psychology Western Michigan University Kalamazoo MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen B","family":"Reitz","sequence":"additional","affiliation":[{"name":"Fox Chase Chemical Diversity Center Inc. Doylestown PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Stevens","family":"Negus","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology Virginia Commonwealth University Richmond VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Rawls","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Temple University School of Medicine Philadelphia PA USA"},{"name":"Center for Substance Abuse Research Temple University School of Medicine Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12445"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12450"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(25)30990-0","article-title":"The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine","volume":"202","author":"Arnold EB","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02214.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.304"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.331"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3223-5"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.155"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378370"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06199.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0112-04.2004"},{"key":"e_1_2_10_13_1","volume-title":"Mephedrone Report","author":"Deluca P","year":"2009"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.04.004"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328364166d"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420118-7.00015-9"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)00348-3"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.06.014"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000006"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.184119"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90012-G"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.094"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(99)00023-5"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90615-1"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90174-7"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01499.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(94)01669-0"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.04.021"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.01998.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3108-7"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.11.001"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90005-M"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00821-2"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00384.x"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113490325"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301414"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007419"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2014.04.009"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(80)90166-5"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2012.06.012"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.053975"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2070-x"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.09.005"},{"key":"e_1_2_10_49_1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(25)21220-4","article-title":"Neurotoxic and pharmacologic studies on enantiomers of the N\u2010methylated analog of cathinone (methcathinone): a new drug of abuse","volume":"279","author":"Sparago M","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(96)80035-7"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2007.00070.x"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0599-5"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62021-1"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03502.x"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03130.x"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044652"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12951","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:47:11Z","timestamp":1746377231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/bph.12951"],"URL":"https:\/\/doi.org\/10.1111\/bph.12951","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]},"assertion":[{"value":"2014-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}